NASDAQ
16.12.25 | 22:00
12,060 US-Dollar
+4,69 % +0,540
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.11. | LENSAR, Inc. - 10-Q, Quarterly Report | 10 | SEC Filings | ||
| 06.11. | LENSAR, Inc. - 8-K, Current Report | 9 | SEC Filings | ||
| 21.10. | LENSAR, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 02.09. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 143 | GlobeNewswire (Europe) | ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors... ► Artikel lesen | |
| 07.08. | LENSAR, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.08. | LENSAR: EPS verfehlt Schätzungen um 0,08 $ - Umsatz schlechter als erwartet | 8 | Investing.com Deutsch | ||
| 07.08. | LENSAR GAAP EPS of -$0.15, revenue of $13.94M | 1 | Seeking Alpha | ||
| LENSAR Aktie jetzt für 0€ handeln | |||||
| 07.08. | LENSAR, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.08. | LENSAR, Inc.: LENSAR Reports Second Quarter 2025 Results and Provides Business Update | 178 | GlobeNewswire (Europe) | 18 ALLY Robotic Cataract Laser Systems ("ALLY Systems") placed in 2Q 2025 with an additional backlog of 18 ALLY Systems pending installation as of June 30, 2025 ALLY installed base grew 107% and total... ► Artikel lesen | |
| 02.07. | LENSAR, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 01.07. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 132 | GlobeNewswire (Europe) | ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted... ► Artikel lesen | |
| 02.06. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 130 | GlobeNewswire (Europe) | ORLANDO, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted... ► Artikel lesen | |
| 08.05. | LENSAR, Inc.: LENSAR Reports First Quarter 2025 Results and Provides Business Update | 258 | GlobeNewswire (Europe) | 14 ALLY Robotic Laser Cataract Systems ("ALLY Systems") placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025 34% Revenue growth over the first... ► Artikel lesen | |
| 24.03. | Alcon Agrees To Acquire LENSAR For Up To Approximately $430 Mln | 540 | AFX News | WASHINGTON (dpa-AFX) - Eye care company Alcon, Inc. (ALC) and medical technology company LENSAR, Inc. (LNSR) announced Monday the companies have entered into a definitive merger agreement through... ► Artikel lesen | |
| 24.03. | Alcon übernimmt Medtech-Unternehmen Lensar für bis zu 430 Millionen Dollar | 1.046 | Moneycab | Genf - Der Augenheilkundespezialist Alcon kauft in den USA zu. Für bis zu 430 Millionen Dollar übernimmt das Genfer Unternehmen das Medizintechnikunternehmen Lensar aus den USA. Lensar ist laut einer... ► Artikel lesen | |
| 24.03. | Alcon Agrees to Acquire LENSAR, Inc. | 496 | Business Wire | Acquisition of ALLY Robotic Cataract Laser Systems strengthens Alcon's cataract equipment and technology portfolio Next generation technology will be expanded globally, improving the efficiency... ► Artikel lesen | |
| 04.03. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 160 | GlobeNewswire (Europe) | ORLANDO, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors... ► Artikel lesen | |
| 27.02. | LENSAR, Inc.: LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update | 229 | GlobeNewswire (Europe) | 31 ALLY Robotic Cataract Laser Systems placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company's total installed systems increased to approximately... ► Artikel lesen | |
| 04.02. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 146 | GlobeNewswire (Europe) | ORLANDO, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted... ► Artikel lesen | |
| 03.01. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 194 | GlobeNewswire (Europe) | ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,210 | -0,38 % | Aktien Frankfurt Ausblick: Dax dürfte vor US-Zinsentscheidung leicht schwächeln | FRANKFURT (dpa-AFX) - Vor der US-Leitzinsentscheidung an diesem Abend dürften die Anleger am deutschen Aktienmarkt einen Gang herunterschalten. Der Dax wurde rund eine Stunde vor Beginn des Börsenhandels... ► Artikel lesen | |
| FRESENIUS | 47,430 | -2,21 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,180 | +0,53 % | FMC, Hugo Boss, Kontron, PVA TePla, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 36,440 | +1,33 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| GENEDX | 141,66 | -5,95 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| CARL ZEISS MEDITEC | 39,940 | -0,45 % | Carl Zeiss Meditec: Auftragsboom, aber Gewinn-Delle - Comeback-Story im TecDAX? | Carl Zeiss Meditec AG liefert zum Geschäftsjahr 2024/25 ein gemischtes, aber durchaus spannendes Bild ab: Umsatz +7,8 % auf 2.228 Mio. Euro, der Auftragseingang legt sogar um +18,2 % zu - doch Gewinn... ► Artikel lesen | |
| HEARTBEAM | 3,435 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| ALIGNMENT HEALTHCARE | 20,030 | -0,40 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| GERRESHEIMER | 27,060 | -3,77 % | Evonik, Gerresheimer, Hugo Boss, K+S, RWE, Siltronic - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BETA BIONICS | 29,630 | -0,30 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CLEARPOINT NEURO | 13,820 | +11,63 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| LUMEXA IMAGING | 17,830 | -3,62 % | Lumexa Imaging Announces Pricing of Initial Public Offering | RALEIGH, N.C., Dec. 10, 2025 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") announced today the pricing of its initial public offering of 25,000... ► Artikel lesen | |
| PROGYNY | 26,020 | -1,29 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| VENUS CONCEPT | 2,260 | 0,00 % | Venus Concept Inc.: Venus Concept Announces Third Quarter 2025 Financial Results | TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three... ► Artikel lesen |
Das Unternehmen LENSAR INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,540 (+4,69 %) liegt der Kurs bei 12,060 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LENSAR INC finden Sie auf Wallstreet Online.